Dr. Roeland is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Division of Hematology and Medical Oncology
3181 SW Sam Jackson Park Road, OC14HO
Portland, OR 97239Phone+1 503-494-8534- Is this information wrong?
Summary
- Eric Roeland, MD, FAAHPM, FASCO, is an Associate Professor at the Oregon Health and Science University. He is a medical oncologist and palliative care specialist whose clinical practice focuses on caring for adults with cancer experiencing poorly controlled symptoms. As the Director of the Knight Cancer Institute Symptom Science Clinical Research Program, his research focuses on Symptom Science, characterizing symptoms' phenotypes and biological underpinnings to develop effective novel clinical interventions to inform clinical practice. He has participated in many industry- and grant-sponsored clinical trials spanning the last decade and has first-hand experience conducting supportive oncology clinical trials.
Education & Training
- University of California (San Diego) Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
- Scripps Mercy HospitalFellowship, Hospice and Palliative Medicine, 2008 - 2009
- University of California (San Diego) Medical CenterResidency, Internal Medicine, 2005 - 2008
- University of Colorado School of Medicine Anschutz Medical CampusClass of 2005
Certifications & Licensure
- CA State Medical License 2007 - Present
- OR State Medical License 2021 - 2025
- WA State Medical License 2023 - 2025
- MA State Medical License 2018 - 2022
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15 Start of enrollment: 2022 Nov 21
- Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer Therapy Start of enrollment: 2020 Oct 07
- A Phase 2 Study of LY2495655 in Participants With Pancreatic Cancer Start of enrollment: 2011 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series.Marianne J Hjermstad, Gunnhild Jakobsen, Jann Arends, Trude Balstad, Leo R Brown, Asta Bye, Andrew J S Coats, Olav F Dajani, Ross D Dolan, Marie T Fallon, Christine Gr...> ;Journal of Cachexia, Sarcopenia and Muscle. 2024 Mar 29
- Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline Q&A.Ilana M Braun, Kari Bohlke, Eric J Roeland> ;JCO Oncology Practice. 2024 Mar 13
- Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline.Ilana M Braun, Kari Bohlke, Donald I Abrams, Holly Anderson, Lynda G Balneaves, Gil Bar-Sela, Daniel W Bowles, Peter R Chai, Anuja Damani, Arjun Gupta, Sigrun Hallmeye...> ;Journal of Clinical Oncology. 2024 Mar 13
- Join now to see all
Press Mentions
- Is Cannabis a Solution for Breast Cancer Patients’ Chemo Side Effects?October 9th, 2022
- Weight Gain Linked to Cancer Survival in Men and WomenSeptember 26th, 2022
- Jaguar Health and Napo Pharmaceuticals Announce Title of Abstract Regarding Patient Outcomes Associated with Cancer Therapy-Related Diarrhea Accepted for Poster Presentation at the American Society of Clinical Oncology 2021 Annual MeetingApril 29th, 2021
- Join now to see all
Professional Memberships
- Fellow
- Fellow
- Multinational Association of Supportive Care in CancerMember
Other Languages
- Spanish
External Links
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: